ES|EN
Skip to content
se habla de ...

Breast units and tumour boards: rethinking the organisational model

A symptom-tracking app lowers the cost of follow-up during adjuvant hormone therapy

Five-year results of PET-guided de-escalation in HER2-positive breast cancer

Specimen ultrasound matches mammography for margin assessment in breast surgery

Delaying breast cancer surgery beyond 30 days is already linked to worse survival

Why antibody-drug conjugates stop working in HER2-low breast cancer

Mammography satisfaction hinges on communication and workflow, not clinical factors

Neoadjuvant chemotherapy makes residual HR+/HER2- tumours more radioresistant

Rapid-relapse triple-negative breast cancer: aggressive tumours and social disadvantage

Immunotherapy with radiotherapy in triple-negative breast cancer: more hypothyroidism

Accredited breast centres report fewer surgical complications

Four questionnaires for breast lymphoedema compared: BLYSS performs best

An oncoplastic team and a digital pathway raise breast conservation to 96%

Sac-TMT confirms its overall survival benefit in advanced triple-negative breast cancer

Young-onset breast cancer burden shifts from Europe to Asia-Pacific

A bispecific antibody doubles progression-free survival in pretreated HR+/HER2- breast cancer

Patient navigation in Brazil: ten fewer days waiting for radiotherapy

T-DM1 with concurrent radiotherapy: case series flags greater toxicity

The ‘time toxicity’ of breast cancer reaches far beyond the clinic visit

Ki-67 that stays high after pre-surgery chemotherapy points to worse prognosis

Oncomama
Oncomama

Papers de oncología de mama y avances de las unidades de mama en España

  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
opciones
  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
  • Breast Units

Breast units and tumour boards: rethinking the organisational model

An analysis asks whether disease-specific units remain justified once multidisciplinary tumour boards and cancer networks are established, and proposes integrating units into the network....

oncomama
J Cancer PolicyNovember 3, 2026
  • Breast Units
  • Treatment

A symptom-tracking app lowers the cost of follow-up during adjuvant hormone therapy

oncomama
JAMA Netw OpenNovember 3, 2026
  • Breast Units
  • Treatment

Five-year results of PET-guided de-escalation in HER2-positive breast cancer

oncomama
Nat MedNovember 2, 2026
  • Surgery & Reconstruction

Specimen ultrasound matches mammography for margin assessment in breast surgery

oncomama
Surg Pract SciNovember 2, 2026
  • Breast Units
  • Research

Delaying breast cancer surgery beyond 30 days is already linked to worse survival

oncomama
Ann Surg OncolNovember 1, 2026
Why antibody-drug conjugates stop working in HER2-low breast cancer
Oncol RepNovember 1, 2026
Mammography satisfaction hinges on communication and workflow, not clinical factors
Breast CareOctober 31, 2026
Neoadjuvant chemotherapy makes residual HR+/HER2- tumours more radioresistant
Adv Radiat OncolOctober 31, 2026
Rapid-relapse triple-negative breast cancer: aggressive tumours and social disadvantage
Breast Cancer ResOctober 30, 2026
Immunotherapy with radiotherapy in triple-negative breast cancer: more hypothyroidism
Oncol LettOctober 30, 2026
Accredited breast centres report fewer surgical complications
Breast CareOctober 29, 2026
Copyright © 2026 | Powered by News Magazine X
oncomama  ·  oncohub  ·  disforia
Desarrollado por dosier.es y diseñado por marta ai